Pedro Pinheiro-Chagas
Assistant Professor, Director of NeuroAI Lab
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Positions (1)
Pedro Pinheiro-Chagas
University of California, San Francisco
9 months ago
The UCSF NeuroAI Lab, directed by Assistant Professor Pedro Pinheiro-Chagas at the University of California, San Francisco, is seeking a postdoctoral fellow to join a cutting-edge research project at the intersection of artificial intelligence, neuroscience, and clinical care. The primary focus is on designing and evaluating AI voice agents to support the diagnosis and care of neurodegenerative diseases, with an initial emphasis on adapting AI systems to administer the Clinical Dementia Rating (CDR®) for Alzheimer’s disease. This project is co-led with Dr. Rachel L. Nosheny (UCSF Brain Health Registry) and Dr. Michael W. Weiner (ADNI), offering a highly collaborative environment that bridges AI, clinical neurology, and psychometrics. The NeuroAI Lab combines generative AI and traditional machine learning with multimodal clinical data to develop human-centered AI systems for healthcare. Research areas include cognitive neuroscience, symbolic cognition, neuroimaging, psychophysics, and neuropsychology, with a strong emphasis on model interpretability, scientific rigor, and data security. The lab is based at the UCSF Fein Memory and Aging Center and is affiliated with the Bakar Computational Health Sciences Institute, Center for Intelligent Imaging, and UCSF Dyslexia Center. Ideal candidates will have strong expertise in machine learning, generative AI, and Python programming, with experience in natural language processing or large language models. Familiarity with clinical or cognitive datasets is preferred. Applicants should hold a doctoral degree in computer science, neuroscience, biomedical engineering, or a related field. The position offers a collaborative clinical and research environment, with opportunities to contribute to impactful research in Alzheimer’s care and neurodegenerative disease diagnosis. The postdoctoral fellowship is fully funded, with salary and benefits provided according to UCSF policy. The application process involves submitting a CV or application to [email protected]. For more details, candidates are encouraged to review the full posting and visit the UCSF NeuroAI Lab website. This is an excellent opportunity for researchers interested in AI for healthcare, neurodegenerative diseases, and interdisciplinary collaboration.
9 months ago
Articles (3)
Developmental dyslexia is a neurodevelopmental condition characterized by persistent reading difficulties despite adequate intelligence and educational opportunities. The cognitive underpinnings of dyslexia remain incompletely understood. Although multiple causal pathways have been proposed, there is a gap in studies that can reliably identify dyslexia subtypes based on comprehensive evaluations that go beyond measures of reading and phonology. We employed one of the largest detailed samples of children with developmental dyslexia resistant to intervention, consisting of 147 extensively phenotyped school-age children aged 7-14 years who were recruited from specialized schools for students with learning differences. We implemented data-driven analyses leveraging a comprehensive neuropsychological assessment to delineate cognitive subdomains and characterize the heterogeneity in the sample. Hierarchical clustering of 24 cognitive measures aided in constructing a framework to subsequently interpret emerging clusters. Four clusters emerged, predominantly associated with: Processing Speed & Executive Function, Visuospatial & Mathematical Reasoning, Phonological Manipulation, and Verbal Short-term Memory & Word Retrieval. Subsequent latent profile analysis identified two distinct dyslexia profiles: one characterized by marked difficulties in executive functioning and processing speed, and another displaying impairments primarily in verbal short-term memory and word retrieval relative to the other profile. Importantly, both profiles exhibited comparable severity of persistent reading difficulties despite their divergent cognitive profiles. These findings show that phenotypically similar reading impairments can arise from distinct underlying cognitive factors, emphasizing the role of comprehensive neuropsychological evaluation in developing tailored interventions for affected children.
Year:
2025
Importance Accurate clinical and pathological diagnoses are essential in neurodegenerative diseases, especially given the emergence of pathology-specific disease-modifying therapies. However, diagnostic accuracy remains challenging due to heterogeneous clinical presentations, complexity of integrating multimodal data, and limited access to multidisciplinary expertise. Primary Progressive Aphasia (PPA) exemplifies these challenges, requiring specialized clinical, neuropsychological, and imaging evaluations. Generative artificial intelligence (AI), powered by large language models, may offer scalable diagnostic support in this context. Objective To evaluate the diagnostic performance of an agentic generative AI system in classifying prototypical PPA cases by clinical syndrome and underlying pathology. Design Retrospective diagnostic validation study using a multi-agent generative AI architecture simulating expert-level reasoning. Setting Single tertiary academic referral center (University of California San Francisco, Memory and Aging Center). Participants Fifty-four individuals with a definite diagnosis of PPA and post-mortem confirmation (18 semantic [svPPA], 17 logopenic [lvPPA], 19 nonfluent [nfvPPA]), selected as prototypical cases with congruent clinical, imaging, and pathological profiles. Exposure Multimodal input data, including clinical notes, neuropsychological and language assessments, and MRI brain images, were processed through a multi-agent architecture. The system generated diagnostic predictions under two conditions: (1) open-ended diagnosis from a set of 15 neurodegenerative clinical syndromes; (2) constrained classification of PPA variant and underlying neuropathology. Main Outcomes and Measures Generative AI system diagnostic accuracy for clinical syndrome and pathology, based on expert clinical diagnoses and post-mortem confirmations as gold standard. Results In the open-ended setting, the system correctly identified PPA in 49 of 54 cases (90.7%, chance level=6.7%). When constrained to PPA, it achieved 100% accuracy for svPPA and nfvPPA, and 94.1% for lvPPA as primary prediction. Neuropathological predictions were most accurate for FTLD-TDP type C (100%) and FTLD-4R tau (100%), and high for Alzheimer’s disease (94.4%). The full diagnostic pipeline of all 54 cases was completed in under 10 minutes. Conclusions and Relevance The AI system demonstrated expert-level performance in classifying prototypical PPA cases, integrating multimodal data and mirroring specialist reasoning. Its speed and accuracy support its potential role in extending access to specialized diagnostic expertise, particularly in non-tertiary settings. Further validation in larger and more heterogeneous populations is warranted.
Year:
2025
Dementia encompasses diverse clinical syndromes where diseases of the brain can manifest as impaired cognitive abilities, such as in Alzheimer’s disease (AD) and behavioral-variant frontotemporal dementia (bvFTD). The diversity of symptom presentations often results in challenges in diagnosis. Crucial clinical information remains in unstructured narrative notes within electronic health records (EHRs). We leverage large language models (LLMs) for symptom phenotyping from notes in UCSF Information Commons, focusing on patients with expert dementia syndrome diagnosed from a multidisciplinary team of specialists from the UCSF Memory and Aging Center. We developed a pipeline to extract findings in a validated structured output, clustered into symptom groups, and then classified patients into syndromes with traditional machine learning paradigms. From over 9,000 cross-referenced patients and over 350,000 specialty-related notes, matched cohorts of bvFTD (122 patients) and AD (170) syndromes were identified. From notes, 12,637 distinct symptom phrases were extracted, with clustering analysis revealing 51 symptom groups. A logistic regression model separated AD and bvFTD with an AUC of 0.83. Disinhibition and obsessive-compulsive behaviors favored bvFTD, while anxiety and visuospatial abnormalities favored AD. This novel approach, combining LLM-based structured information extraction with traditional interpretable prediction paradigms, demonstrates a promising approach for enhanced symptom characterization in dementia. Our findings suggest potential future applications in improving diagnostic accuracy, developing prediction models, and optimizing treatment strategies in dementia care.
Year:
2025
Collaborators (13)
Boon Lead Tee
Assistant Professor
University of California, San Francisco
Maria Luisa Mandelli
Associate Professor
University of California, San Francisco
tomiko oskotsky
University of California, San Francisco
Zachary Miller
Professor
-
Bruce Miller
A.W. and Mary Margaret Clausen Distinguished Professor
University of California, San Francisco
Maria Luisa Gorno Tempini
Professor of Neurology and Psychiatry
University of California, San Francisco
Marina Sirota
University of California, San Francisco
Howard Rosen
Professor
University of California, San Francisco
Lea T. Grinberg
-
Jet M. J Vonk
Assistant Professor
UCSF Medical Center
Salvatore Spina
Associate Professor
University of California, San Francisco
William Seeley
University of California, San Francisco
Chiara Gallingani
University of Modena and Reggio Emilia
Make your next move.
Prepare your application
Review drafts before you send them.